You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

bispecific

Showing 26 - 50 of 569
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hepatocellular Carcinoma Trial (AK112)

Not yet recruiting
  • Hepatocellular Carcinoma
  • (no location specified)
Jun 24, 2022

B-Cell Lymphoma Trial in Heidelberg, Melbourne, Nedlands (TG-1801, Ublituximab)

Active, not recruiting
  • B-Cell Lymphoma
  • Heidelberg, Victoria, Australia
  • +2 more
Jan 20, 2023

Myeloproliferative Disorders, Essential Thrombocythemia, Tumors Trial (JNJ-88549968)

Not yet recruiting
  • Myeloproliferative Disorders
  • +3 more
  • (no location specified)
Nov 21, 2023

Advanced Solid Tumor Trial (ES014)

Withdrawn
  • Advanced Solid Tumor
  • (no location specified)
Jan 30, 2023

Prostate Cancer Recurrent Trial in Tuebingen (CC-1 Infusion)

Recruiting
  • Prostate Cancer Recurrent
  • CC-1 Infusion
  • Tuebingen, Germany
    University Hospital Tuebingen
Jan 10, 2023

Advanced Malignant Tumors(Stage IA-IB) Trial in Beijing (AK129 IV infusion)

Not yet recruiting
  • Advanced Malignant Tumors(Stage IA-IB)
  • AK129 IV infusion
  • Beijing, Beijing, China
    Cancer Hospital Chinese Academy of Medical Science
Jan 17, 2023

Pediatric Cancer, Hodgkin Disease, CD30-Positive DLBCL Trial in Milwaukee (anti-CD30 Bispecific Antibody-armed

Not yet recruiting
  • Pediatric Cancer
  • +11 more
  • anti-CD30 Bispecific Antibody-armed anti-CD3-Activated Autologous T-cells (CD30 biAb-AATC)
  • Milwaukee, Wisconsin
    Children's Wisconsin
Sep 14, 2022

Advanced Adenocarcinoma Trial (BA3182)

Not yet recruiting
  • Advanced Adenocarcinoma
  • (no location specified)
Apr 10, 2023

Sarcoma, Soft Tissue Trial in Changsha (Cardunilizumab)

Active, not recruiting
  • Sarcoma, Soft Tissue
  • Changsha, Hunan, China
    Xiangya Hospital Central South University
Oct 29, 2023

Tumors Malignant Trial in Shanghai (B1962)

Not yet recruiting
  • Neoplasms Malignant
  • Shanghai, Shanghai, China
    Shanghai Pulmonary Hospital
Dec 13, 2022

Advanced Solid Tumors Trial in China (IMM2510)

Recruiting
  • Advanced Solid Tumors
  • Luoyang, Henan, China
  • +3 more
Jul 25, 2023

Locally Advanced or Metastatic Solid Tumors, NSCLC Trial in Australia (HLX301)

Recruiting
  • Locally Advanced or Metastatic Solid Tumors
  • Non-small Cell Lung Cancer
  • Blacktown, New South Wales, Australia
  • +4 more
May 25, 2022

Locally Advanced or Metastatic Epithelial Tumor Trial in Guangzhou (SI-B001)

Active, not recruiting
  • Locally Advanced or Metastatic Epithelial Tumor
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Mar 14, 2022

CS1+ or BCMA+ Multiple Myeloma Trial in Wuhan (Conditioning chemo followed by CAR T cell infusion)

Recruiting
  • CS1+ or BCMA+ Multiple Myeloma
  • Conditioning chemotherapy followed by CAR T cell infusion
  • Wuhan, Hubei, China
    Union Hospital, Tongji Medical College, Huazhong University of S
Feb 11, 2022

Solid Tumor, Lymphoma Trial (LB1410)

Recruiting
  • Solid Tumor
  • Lymphoma
  • Shanghai, Shanghai, China
    Shanghai Pulmonary Hospital
Dec 27, 2022

Multiple Myeloma Trial in Spain (REGN5458, Daratumumab, Carfilzomib)

Recruiting
  • Multiple Myeloma
  • Athens, Greece
  • +8 more
Nov 30, 2022

Recurrent or Metastatic Cervical Cancer Trial in Changsha, Hangzhou (AK104, Bevacizumab, Paclitaxel)

Active, not recruiting
  • Recurrent or Metastatic Cervical Cancer
  • AK104
  • +3 more
  • Changsha, Hunan, China
  • +1 more
Mar 28, 2022

Lung Cancer Squamous Cell Trial in Stuttgart, Tuebingen (CC-1 and Toczilizumab)

Recruiting
  • Lung Cancer Squamous Cell
  • CC-1 and Toczilizumab
  • Stuttgart, BW, Germany
  • +1 more
Feb 2, 2022

Ovarian Cancer Trial (AK104 - Chemotherapy)

Not yet recruiting
  • Ovarian Cancer
  • AK104 - Chemotherapy
  • (no location specified)
Jun 20, 2022

Malignant Glioma, Glioblastoma Trial in Durham (hEGFRvIII-CD3 (BRiTE), Activated Cell Therapy)

Not yet recruiting
  • Malignant Glioma
  • Glioblastoma
  • hEGFRvIII-CD3 (BRiTE)
  • Activated Cell Therapy
  • Durham, North Carolina
    Duke University Medical Center
Jun 24, 2022

Multiple Myeloma Trial (Linvoseltamab)

Not yet recruiting
  • Multiple Myeloma
  • (no location specified)
Apr 12, 2023

Solid Tumor, Adult Trial (HLX35, HLX10)

Not yet recruiting
  • Solid Tumor, Adult
  • (no location specified)
Jun 29, 2022

Advanced Malignant Tumor Trial in Guangzhou (BAT7104 injection)

Recruiting
  • Advanced Malignant Tumor
  • BAT7104 injection
  • Guangzhou, Guangdong, China
    Li Zhang
Mar 1, 2023

Advanced Malignant Tumors Trial in Shanghai (AK104, AK117, Capecitabine tablets)

Recruiting
  • Advanced Malignant Tumors
  • Shanghai, China
    Shanghai Renji Hospital
Aug 9, 2022

Relapsed or Refractory Multiple Myeloma Trial in Tianjin (QLS32015)

Recruiting
  • Relapsed or Refractory Multiple Myeloma
  • Tianjin, Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
Jun 24, 2023